Background: Appropriate counseling and treatment for women with multiple sclerosis (MS) who may become pregnant requires an understanding of the effects of exposure to disease-modifying therapies (DMTs) during pregnancy. Current reports and studies are limited in their usefulness, mostly by small sample size. Branded glatiramer acetate (GA) is a DMT approved for the treatment of relapsing forms of MS. For more than 2 decades, it has been shown to be efficacious and to have a favorable safety profile. The Teva Pharmaceutical Industries Ltd global pharmacovigilance database comprises data from more than 7000 pregnancies, during which women with MS were exposed to treatment with branded GA.
Methods: We analyzed data from Teva's global pharmacovigilance database. Pregnancy outcomes for patients treated with branded GA were compared with reference rates of abnormal pregnancy outcomes reported in two large registries representing the general population.
Results: Pregnancies exposed to branded GA were not at higher risk for congenital anomalies than what is expected in the general population.
Conclusions: These data provide evidence that branded GA exposure during pregnancy seems safe, without teratogenic effect.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825987 | PMC |
| http://dx.doi.org/10.7224/1537-2073.2016-079 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Maternal mortality in Italy estimated by the Italian Obstetric Surveillance System.
Sci Rep
December 2024
National Centre for Diseases Prevention and Health Promotion, Istituto Superiore di Sanità, Rome, Italy.
This study aimed to calculate Italy's first national maternal mortality ratio (MMR) through an innovative record-linkage approach within the enhanced Italian Obstetric Surveillance System (ItOSS). A record-linkage retrospective cohort study was conducted nationwide, encompassing all women aged 11-59 years with one or more hospitalizations related to pregnancy or pregnancy outcomes from 2011 to 2019. Maternal deaths were identified by integrating data from the Death Registry and national and regional Hospital Discharge Databases supported by the integration of findings from confidential enquiries conducted through active surveillance.
View Article and Find Full Text PDFMaternal postpartum infection risk following induction of labor: A Danish national cohort study.
Acta Obstet Gynecol Scand
December 2024
Department of Gynecology and Obstetrics, Copenhagen University Hospital-North Zealand, Denmark.
Introduction: Induction of labor is a common procedure, and in Denmark, approximately one in four vaginal deliveries are induced. The association between induction and maternal postpartum infections such as endometritis, surgical site infection after cesarean section, urinary tract infection, and sepsis has been sparsely investigated. Our objective was to investigate the association between induction of labor and risk of maternal postpartum infection and to identify potential risk factors for infection.
View Article and Find Full Text PDFPrevalence of unintended pregnancy and associated factors among pregnant women with disabilities in Ethiopia: from the social model of disability perspective.
Front Glob Womens Health
December 2024
Department of Epidemiology and Public Health, School of Life Science, Central University of Tamil Nadu, Thiruvarur, India.
Background: In low-income countries, women with disabilities face numerous challenges in accessing sexual and reproductive health services and experience high unintended pregnancy rates and adverse pregnancy outcomes, with 42% of cases ending in abortion. However, little is known about unintended pregnancy among women with disabilities in Ethiopia. Therefore, this study aimed to assess the prevalence of unintended pregnancy and associated factors among women with disabilities in the Central Regional State of Ethiopia.
View Article and Find Full Text PDFInfluence of Warning Bleeding on Blood Loss in Low-Lying Placenta.
Cureus
November 2024
Department of Obstetrics and Gynecology, Niigata University Medical and Dental Hospital, Niigata, JPN.
Objective This study aimed to investigate whether the amount of blood loss during delivery in patients with low-lying placenta is affected by the planned mode of delivery, internal os distance, and warning bleeding. Materials and methods We conducted a single-center retrospective study encompassing women with singleton pregnancies diagnosed with low-lying placenta between January 2012 and December 2021. Data for maternal demographic details and pregnancy outcomes were extracted from the institution's records.
View Article and Find Full Text PDFImmediate postplacental intrauterine device placement: retrospective cohort study of expulsion and associated risk factors.
AJOG Glob Rep
February 2025
Department of Obstetrics and Gynecology, University of Rochester Medical Center, University of Rochester School of Medicine and Dentistry, Rochester, NY (Leubner, Levandowski, Mikami, and Betstadt).
Background: Postpartum contraception is typically provided during postpartum visits. When desired and accessible, the immediate postpartum period provides an additional opportunity to increase the use of more effective contraceptive methods to potentially reduce subsequent unintended pregnancies and improve pregnancy outcomes. In New York State, recent policy changes expanded Medicaid coverage to include immediate postplacental intrauterine device insertion.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!